🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 8 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
16/02/2018 5,85 5,95 5,46 5,57 -4,46% 8,38% 1.199.000
15/02/2018 5,51 5,90 5,41 5,83 +6,58% 8,89% 1.422.900
14/02/2018 5,10 5,55 5,01 5,47 +6,01% 10,59% 868.200
13/02/2018 5,20 5,42 4,77 5,16 -2,82% 12,50% 2.050.500
12/02/2018 5,42 5,65 5,30 5,31 -5,01% 6,46% 1.627.000
09/02/2018 5,75 5,98 5,38 5,59 -1,24% 10,43% 1.245.000
08/02/2018 5,92 6,04 5,63 5,66 -3,41% 6,93% 835.000
07/02/2018 5,69 6,11 5,67 5,86 +2,63% 7,80% 1.145.800
06/02/2018 5,36 5,73 5,14 5,71 +4,77% 11,01% 1.533.500
05/02/2018 5,81 5,87 5,41 5,45 -7,63% 7,92% 1.316.200
02/02/2018 6,03 6,15 5,83 5,90 -4,07% 5,31% 1.353.300
01/02/2018 6,15 6,28 6,08 6,15 -0,49% 3,17% 769.300
31/01/2018 6,23 6,35 6,03 6,18 +0,65% 5,14% 756.300
30/01/2018 6,10 6,20 5,87 6,14 -0,49% 5,33% 1.338.100
29/01/2018 6,24 6,33 6,06 6,17 +0,82% 4,25% 923.900
26/01/2018 6,29 6,35 6,11 6,12 -2,70% 3,82% 768.900
25/01/2018 6,19 6,38 6,06 6,29 +2,95% 5,17% 970.900
24/01/2018 6,31 6,43 5,84 6,11 -2,71% 9,43% 2.069.800
23/01/2018 6,46 6,59 6,24 6,28 -1,72% 5,42% 2.269.700
22/01/2018 6,31 6,75 6,27 6,39 +1,59% 7,61% 3.043.300
19/01/2018 5,82 6,40 5,74 6,29 +9,97% 11,34% 4.723.100
18/01/2018 5,41 5,81 5,40 5,72 +0,00% 7,58% 5.108.700
17/01/2018 5,59 5,86 5,37 5,72 +2,14% 8,77% 1.863.600
16/01/2018 5,90 5,91 5,30 5,60 -2,10% 10,27% 2.922.100
12/01/2018 5,17 6,25 5,01 5,72 +13,49% 23,97% 7.345.100
11/01/2018 4,44 5,47 4,37 5,04 +14,55% 24,77% 4.867.200
10/01/2018 4,57 4,71 4,31 4,40 -4,76% 8,75% 1.966.300
09/01/2018 4,58 4,90 4,46 4,62 +1,54% 9,72% 1.430.400
08/01/2018 4,88 4,90 4,37 4,55 -6,57% 10,86% 2.658.900
05/01/2018 4,86 5,23 4,66 4,87 +0,41% 11,73% 2.278.200